HOME >> BIOLOGY >> NEWS
Alzheimer's study first to explain death of brain cells

Researchers at Children's Hospital & Research Center at Oakland (CHRCO) have published a new study that is the first to explain how brain cells die in patients with Alzheimer's Disease. This discovery is an important first step to helping researchers devise ways to slow, prevent and eventually cure a disease that affects an estimated 4.5 million Americans.

In a study published in the February 28th issue of the Proceedings of the National Academy of Sciences, lead scientist Hani Atamna, Ph.D., found that alterations in the production of heme (a molecule that contains iron) may be the key to understanding why excessive amyloid-beta is toxic to brain cells. Dr. Atamna had previously discovered that Alzheimer's patients have abnormal amounts of heme in their brains. In new research results, Atamna's team showed that amyloid-beta readily binds with heme to form a compound that can be flushed from cells. When there is insufficient heme or too much amyloid-beta, however, the amyloid-beta forms large toxic "clumps" that the cell cannot dissolve and eliminate.

Though heme binding with amyloid-beta can be beneficial, if too much heme is bound up with amyloid-beta, there may be insufficient heme available for the cell to properly function. When this happens, the cell's mitochondria, which are the tiny structures inside brain cells that produce the energy the cells need to function, begin to decay. Dr. Atamna refers to this phenomenon as a "functional heme deficiency" because the cells are still forming heme, but it is trapped within an amyloid-beta/heme compound.

When they examined the heme/ amyloid-beta compound researchers in the Atamna laboratory were surprised to discover it was a peroxidase--a type of enzyme that reacts harmfully with biological materials essential for proper brain function such as serotonin and L-DOPA. Dr. Atamna believes that the combination of functional heme deficiency, which harms mitochondria needed to produce energy, tog
'"/>

Contact: Venita Robinson
vrobinson@mail.cho.org
510-428-3069
Children's Hospital & Research Center at Oakland
14-Mar-2006


Page: 1 2

Related biology news :

1. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
2. Link identified between Alzheimers disease and glaucoma
3. UCF research links proteins, stem cells and potential Alzheimers treatment
4. Journal of Alzheimers Disease achieves significant impact factor
5. Alzheimers prevention role discovered for prions
6. Cloned pigs help scientists towards a breakthrough in Alzheimers
7. Alzheimers drug based on Purdue -- designed inhibitor begins clinical trials
8. Paving the way toward a vaccine against Alzheimers disease
9. Genetic fellow traveler discovered in Alzheimers
10. New clues to stroke role in Alzheimers
11. Research team identifies new Alzheimers gene

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 09, 2019 , ... ... hM4Di ligands – exciting compounds for scientists studying GPCR and DREADD signalling. Hello ... and the National Institute of Neurological Disorders and Stroke, both institutes of the ...
(Date:2/27/2019)... ... 2019 , ... Fluxion Biosciences, a leading developer of precision solutions for life ... grant for further development of its ERASE-Seq liquid biopsy technology. The Phase I grant ... Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the potential to ...
(Date:2/22/2019)... ... February 20, 2019 , ... ... precision medicine, the traditional line between engineering and medical science grows ever thinner. ... smarter, the medical device industry is making medical practice easier for doctors, more ...
Breaking Biology News(10 mins):
(Date:3/19/2019)... ... March 19, 2019 , ... ... in Israel and the Middle East region, and Swiss-based CDMO Lonza announced ... platform. The partnership will enable Sheba to vastly streamline its in-house cell ...
(Date:3/14/2019)... PRINCETON, N.J. (PRWEB) , ... March 14, 2019 , ... ... will create challenges for companies to keep up. Traditional Regulatory intelligence ... times and adapting technology to get global Regulatory teams right Insights faster and cheaper. ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... gold standard solution for preclinical research organizations. It is a low code, ... connected systems and facilities, innovative technology-driven automated data capture and seamless data ...
(Date:3/9/2019)... SAN DIEGO (PRWEB) , ... March 07, 2019 ... ... Agilent Technologies, is a pioneer in the development and commercialization of high performance, ... and PhysioStim, a leading European CRO with GLP-certified expertise in cardiovascular pharmacology and ...
Breaking Biology Technology:
Cached News: